466100 — Clobot Co Balance Sheet
0.000.00%
- KR₩1tn
- KR₩1tn
- KR₩33bn
Annual balance sheet for Clobot Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 7,958 | 13,340 | 21,169 | 52,342 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 2,765 | 2,513 | 5,700 | 8,623 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 12,108 | 18,339 | 29,922 | 65,670 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 693 | 2,279 | 2,058 | 1,798 |
| Net Goodwill | ||||
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Long Term Notes Receivable | ||||
| Other Long Term Assets | ||||
| Total Assets | 13,526 | 22,189 | 34,595 | 69,511 |
| Accounts Payable | ||||
| Payable / Accrued | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 20,164 | 23,036 | 6,985 | 8,027 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Minority Interest | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 23,454 | 35,443 | 8,845 | 9,602 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| ESOP Debt Guarantee | ||||
| Other Equity | ||||
| Total Equity | -9,929 | -13,255 | 25,749 | 59,909 |
| Total Liabilities & Shareholders' Equity | 13,526 | 22,189 | 34,595 | 69,511 |
| Total Common Shares Outstanding |